VelaLabs GmbH
Andreas Nechansky is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as CEO and Qualified Person at VelaLabs GmbH since July 2023. Previously, Nechansky held several significant roles, including Managing Director and Site Manager for ABF Pharmaceutical Services, where responsibilities encompassed GMP warehousing, packaging, and quality services. Nechansky also contributed as VP of Research and Analytical Operations at Eden Biologics, focusing on biosimilar development and assay methodologies. Prior experience includes founding and leading operations at VelaLabs GmbH, emphasizing GMP compliance and analytical services. Nechansky's career began with research roles at Igeneon GmbH, The Scripps Research Institute, and Novartis, with a strong foundation in molecular genetics from the University of Vienna, complemented by a postgraduate study in pharmaceutical quality management.
This person is not in any teams
This person is not in any offices
VelaLabs GmbH
VelaLabs - founded 2006 - is a GLP and GMP-certified and G(C)LP compliant contract laboratory focusing on analytical and quality services of biopharmaceutical products supporting BIOTECH and PHARMA companies in the clinical development of biosimilars, biologics and ATMPs. By the acquisition of LABH in 2019 and building a clean room in 2020, VelaLabs also offers all types of microbiological services. Together with its strong team, the VelaLabs Management aims to successfully realize its vision of being a trusted partner for our customers along the process of medication development.